AAgilent Technologies
Deals with insiders in the proxy filed 2026-02-06
Deals between A and its directors, executives, owners of more than 5% or their families: a relative on the payroll, a plane the company charters from its CEO, a director's company that buys from it. SEC rules (Item 404) make the company list every such deal over $120,000 in its proxy statement.
New this year
Paragraphs about a deal, a person or a relative with nothing like them in the proxy filed 2025-01-31.
Nothing new: every deal in this year's section was reported last year too.
The whole section
8 paragraphs quoted as filed
Related Person Transactions Policy and Procedures“Our Standards of Business Conduct and Director Code of Ethics require that all employees and directors avoid conflicts of interests that interfere with the performance of their duties or the best interests of the company. In addition, we have adopted a written Related Person Transactions Policy and Procedures (the “Related Person Transactions Policy”) that prohibits any of our executive officers, directors or any of their immediate family members from entering into a transaction with the Company, except in accordance with the policy. For purposes of the policy, a “related person transaction” includes any transaction involving the Company and any related person that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K.”
Read it in the proxy ↗
Related Person Transactions Policy and Procedures“Our Related Person Transactions Policy provides that the Nominating/Corporate Governance Committee or, at the Nominating/Corporate Governance Committee’s request, the disinterested members of the Board review related person transactions in accordance with the terms of the policy. In making the determination whether to approve or ratify a transaction, the Nominating/Corporate Governance Committee or the disinterested members of the Board shall consider all relevant available information and, as appropriate, must take into consideration the following:”
Read it in the proxy ↗
Related Person Transactions Policy and Procedures“whether the transaction may involve a conflict of interest; and • whether the transaction involves the provision of goods or services to the company that are available from unaffiliated third parties and, if so, whether the transaction is on terms and made under circumstances that are at least as favorable to the Company as would be available in comparable transactions with or involving unaffiliated third parties.”
Read it in the proxy ↗
Related Person Transactions Policy and Procedures“The Related Person Transactions Policy provides for standing pre-approval of the following transactions with related persons:”
Read it in the proxy ↗
Related Person Transactions Policy and Procedures“Any transaction with another company at which a related person’s only relationship is as an employee (other than an executive officer or an equivalent), director or beneficial owner of less than 10% of that company’s shares, if the aggregate amount involved does not exceed the greater of (i) $1,000,000, or (ii) 2 percent of that company’s total annual revenues.”
Read it in the proxy ↗
Related Person Transactions Policy and Procedures“Any charitable contribution, grant or endowment by the company to a charitable organization, foundation or university at which a related person’s only relationship is as an employee (other than an executive officer or an equivalent), a director or a trustee, if the aggregate amount involved does not exceed the lesser of (i) $500,000, or (ii) 2 percent of the charitable organization’s total annual receipts.”
Read it in the proxy ↗
Transactions with Related Persons“We purchase services, supplies, and equipment in the normal course of business from many suppliers and sell or lease products and services to many customers. In some instances, these transactions occur with companies with which members of our management or Board have relationships as directors or executive officers. For transactions entered into during fiscal year 2025, no related person had or will have a direct or indirect material interest. While not required under the policy, the members of the Nominating/Corporate Governance Committee, excluding the respective related person for his or her company’s transactions only, reviewed, approved and ratified certain ordinary course commercial transactions with AstraZeneca, Pfizer, and the University of Texas Southwestern Medical Center (“UTSW”).”
Read it in the proxy ↗
Transactions with Related Persons“Pascal Soriot is the Chief Executive Officer and President of AstraZeneca and Daniel K. Podolsky, M.D., is the President of UTSW. During fiscal year 2025, Mikael Dolsten, M.D., Ph. D., served as the President of Worldwide Research, Development and Medical, Chief Scientific Officer and Executive Vice President of Pfizer and retired from Pfizer in all capacities in February 2025.”
Read it in the proxy ↗
Paragraphs are compared by their words, not read by AI: one counts as new when no paragraph last year shares half of its words, or when it names a person or company last year's section did not. A deal reported again with a new amount is not new. Always check the filing. Open the proxy ↗ · Last year's proxy ↗